Press Releases
Press Releases
Regeneron’s Antibody Cocktail REGN-EB3 is First FDA-Approved Treatment for Ebola
Regeneron Pharmaceuticals, Inc. announced that the U.S. FDA approved Inmazeb® (atoltivimab, maftivimab and odesivimab-ebgn) for the treatment of infection caused by Zaire ebolavirus in adult and pediatric patients, including newborns of mothers who have tested positive for the infection.
“We...
Press Releases
TraceLink VRS Solution Implemented by Henry Schein Months Ahead of Deadline for DSCSA Saleable Returns Verification Requirement
TraceLink Inc., the leading digital platform company for the life sciences supply chain, announced that Henry Schein, the world’s largest provider of health care solutions to office-based dental and medical practitioners, has implemented TraceLink’s verification router service (VRS) solution....
Press Releases
Merck’s New VirusExpress Platform Speeds Development of Cell and Gene Therapies
Merck, a leading science and technology company, has bolstered its viral vector manufacturing capabilities with the launch of its VirusExpress™ Lentiviral Production Platform. This new platform helps to overcome lentiviral production challenges and can reduce process development time by...
Packaging & Labelling
Dnata becomes first to offer fully integrated, temperature-controlled cool chain for pharma cargo in Singapore
dnata, one of the world’s leading air services providers, has further enhanced its pharma handling capabilities in Singapore by launching cool dollies in its operations.
The company’s new, high-tech containers are specially designed to serve the pharmaceutical industry with a...
Press Releases
Roche to launch laboratory SARS-CoV-2 antigen test to support high-volume testing of suspected COVID-19 patients
Roche announced that it intends to launch a high-volume SARS-CoV-2 Antigen test as an aid in the diagnosis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. The test is planned to be made available at the end of...
Drug Research
FUJIFILM Diosynth Biotechnologies Stands Ready to Manufacture Lilly COVID-19 Antibody for Low- and Middle-Income Countries
FUJIFILM Diosynth Biotechnologies, a world leading Contract Development and Manufacturing Organization (CDMO) for biologics, viral vaccines and viral vectors, announced that it will manufacture Eli Lilly and Company’s COVID-19 therapeutic antibody at its GMP facility in Hillerød, Denmark, deploying...
Press Releases
Thermo Fisher Scientific Further Expands COVID-19 Test Portfolio with Two New Antibody Tests
Thermo Fisher Scientific Inc., the world leader in serving science, introduced two new SARS-CoV-2 antibody tests: the Thermo Scientific OmniPATH COVID-19 Total Antibody ELISA test, and the Thermo Scientific EliA SARS-CoV-2-Sp1 IgG test. These new tests for detecting COVID-19...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read















